药学实践杂志
藥學實踐雜誌
약학실천잡지
THE JOURNAL OF PHARMACEUTICAL PRACTICE
2015年
1期
83-87
,共5页
樊蓉%任天舒%赵庆春%史国兵
樊蓉%任天舒%趙慶春%史國兵
번용%임천서%조경춘%사국병
中西药联用%冠心病心绞痛%疗效%荟萃分析
中西藥聯用%冠心病心絞痛%療效%薈萃分析
중서약련용%관심병심교통%료효%회췌분석
combination of Chinese and western medicine%angina pectoris%efficacy%Meta-analysis
目的:系统评价西药常规合用通心络胶囊治疗冠心病心绞痛的疗效。方法运用计算机检索2000年至2011年中国期刊网全文数据库(CNKI)、万方数据库、维普数据库和 PubMed ,并结合手工文献检索相关杂志、会议论文和学位论文,收集国内外公开发表的西药常规治疗+通心络胶囊治疗冠心病心绞痛的随机对照试验(RC T )。由2名研究者独立选择试验、评价质量、提取数据,并交叉核对。使用RevMan 4.2.2软件进行分析。结果纳入西药常规+通心络胶囊(治疗组)与西药常规(对照组)对照评价治疗冠心病心绞痛有效率的RC T 11项,其中9项评价了心电图异常的改善率,11项评价了心绞痛症状的改善率。心电图疗效评价,治疗组相对于对照组相对危险度(RR)值为1.40(95% CI:1.28~1.54),P<0.01;心绞痛症状疗效评价,治疗组相对于对照组 R R值为1.25(95% C I:1.18~1.32),P<0.01。治疗组仅个别病例有轻微胃肠不适。结论在西医常规治疗的基础上合用通心络胶囊,能有效提高临床疗效,用药安全。
目的:繫統評價西藥常規閤用通心絡膠囊治療冠心病心絞痛的療效。方法運用計算機檢索2000年至2011年中國期刊網全文數據庫(CNKI)、萬方數據庫、維普數據庫和 PubMed ,併結閤手工文獻檢索相關雜誌、會議論文和學位論文,收集國內外公開髮錶的西藥常規治療+通心絡膠囊治療冠心病心絞痛的隨機對照試驗(RC T )。由2名研究者獨立選擇試驗、評價質量、提取數據,併交扠覈對。使用RevMan 4.2.2軟件進行分析。結果納入西藥常規+通心絡膠囊(治療組)與西藥常規(對照組)對照評價治療冠心病心絞痛有效率的RC T 11項,其中9項評價瞭心電圖異常的改善率,11項評價瞭心絞痛癥狀的改善率。心電圖療效評價,治療組相對于對照組相對危險度(RR)值為1.40(95% CI:1.28~1.54),P<0.01;心絞痛癥狀療效評價,治療組相對于對照組 R R值為1.25(95% C I:1.18~1.32),P<0.01。治療組僅箇彆病例有輕微胃腸不適。結論在西醫常規治療的基礎上閤用通心絡膠囊,能有效提高臨床療效,用藥安全。
목적:계통평개서약상규합용통심락효낭치료관심병심교통적료효。방법운용계산궤검색2000년지2011년중국기간망전문수거고(CNKI)、만방수거고、유보수거고화 PubMed ,병결합수공문헌검색상관잡지、회의논문화학위논문,수집국내외공개발표적서약상규치료+통심락효낭치료관심병심교통적수궤대조시험(RC T )。유2명연구자독립선택시험、평개질량、제취수거,병교차핵대。사용RevMan 4.2.2연건진행분석。결과납입서약상규+통심락효낭(치료조)여서약상규(대조조)대조평개치료관심병심교통유효솔적RC T 11항,기중9항평개료심전도이상적개선솔,11항평개료심교통증상적개선솔。심전도료효평개,치료조상대우대조조상대위험도(RR)치위1.40(95% CI:1.28~1.54),P<0.01;심교통증상료효평개,치료조상대우대조조 R R치위1.25(95% C I:1.18~1.32),P<0.01。치료조부개별병례유경미위장불괄。결론재서의상규치료적기출상합용통심락효낭,능유효제고림상료효,용약안전。
Objective To assess the effectiveness of western routine treatments combined with Tongxinluo capsule for angina pectoris .Methods The randomized controlled trials(RCTs ) of western routine treatments combined with tongxinluo capsule for angina pectoris were collected through searching on computer from the following databases ,CNKI (2000 -2011 ) ,WanFang Data (2000 -2011) ,WeiPu Data(2000-2011) ,PubMed(2000-2011) and manual search relevant journals ,conference papers .Results A total of 11 studies were included and improvement rate of abnormal ECG were estimated in 9 studies and improvement rate of symptoms of angina were estimated in 11 studies .ECG clinical evaluation of the treatment group relative to the control group ,relative risk (RR) value was 1 .40 (95% CI:1 .28‐1 .54) ,P<0 .01 ,symptoms of angina clinical evaluation ,treatment group relative to the control group RR value of 1.25 (95% CI:1 .18‐1 .32) ,P<0 .01 .Only slight gastrointestinal discomfort were found in treatment group .Conclusion Tongxinluo capsule in combination on the basis of conventional western treatment could effectively improve the clinical efficacy and drug safety .